NewAmsterdam Pharma Company N.V.

NAMS ·Healthcare, Drug Manufacturers - General, Netherlands
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 2, 2026 4
8-K Sep 29, 2026 8-K
SCHEDULE 13D/A Sep 22, 2026
8-K Sep 21, 2026 8-K
4 Sep 15, 2026 4
4 Sep 9, 2026 4
4 Sep 3, 2026 4
144/A Aug 25, 2026
4 Aug 25, 2026 4
144 Aug 24, 2026
8-K/A Aug 14, 2026 8-K/A
3 Aug 14, 2026 3
8-K Aug 14, 2026 8-K
SCHEDULE 13G/A Aug 6, 2026
8-K Aug 5, 2026 8-K
10-Q Aug 5, 2026 10-Q
8-K Jul 24, 2026 8-K
8-K Jul 22, 2026 8-K
4 Jul 22, 2026 4
4 Jun 24, 2026 4
S-8 Jun 5, 2026 S-8
SCHEDULE 13G/A Jun 4, 2026
8-K Jun 3, 2026 8-K
4 May 27, 2026 4
144 May 26, 2026
← Newer Page 1 of 17 · 412 filings Older →